Lyophilized S95014

DRUG2 trials

Sponsors

Institut de Recherches Internationales Servier

Conditions

Acute Lymphoblastic Leukemia

Phase 2

A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL)

CompletedNCT04954326

Institut de Recherches Internationales ServierAcute Lymphoblastic Leukemia

Start: 2021-05-07End: 2022-05-20Updated: 2023-07-12

A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL)

CompletedNCT04956666

Institut de Recherches Internationales ServierAcute Lymphoblastic Leukemia

Start: 2021-06-15End: 2023-01-23Updated: 2023-12-29